Accueil>>Signaling Pathways>> Proteases>> Acyltransferase>>Beauvericin

Beauvericin

Catalog No.GC17342

La beauvéricine est une mycotoxine de Fusarium.

Products are for research use only. Not for human use. We do not sell to patients.

Beauvericin Chemical Structure

Cas No.: 26048-05-5

Taille Prix Stock Qté
1mg
43,00 $US
En stock
5mg
189,00 $US
En stock
10mg
355,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Beauvericin is a mycotoxin originally derived from B. bassiana, a common fungal parasite of arthropods. It is also produced by the fungus Fusarium, a pathogen of insects and plants.[1] Beauvericin is cytotoxic against insect cells, killing the insect cell line SF-9 with a 50% cytotoxic concentration of 2.5 μM.[2] In mammalian cells, beauvericin induces apoptosis with an IC50 value of 4.5 μM.[1],[3]

Reference:
[1]. Logrieco, A., Moretti, A., Castella, G., et al. Beauvericin production by Fusarium species. Applied and Environmental Microbiology 64(8), 3084-3088 (1998).
[2]. Calo, L., Fornelli, F., Nenna, S., et al. Beauvericin cytotoxicity to the invertebrate cell line SF-9. J.Appl.Genet. 44(4), 515-520 (2003).
[3]. Tonshin, A.A., Teplova, V.V., Andersson, M.A., et al. The Fusarium mycotoxins enniatins and beauvericin cause mitochondrial dysfunction by affecting the mitochondrial volume regulation, oxidative phosphorylation and ion homeostasis. Toxicology 276, 49-57 (2010).

Avis

Review for Beauvericin

Average Rating: 5 ★★★★★ (Based on Reviews and 33 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Beauvericin

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.